Rajasingham R, Smith RM, Park BJ et al (2017) Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis. Lancet Infect Dis 17:873–881
PubMed PubMed Central Google Scholar
Loyse A, Burry J, Cohn J et al (2019) Leave no one behind: response to new evidence and guidelines for the management of Cryptococcal meningitis in low-income and middle-income countries. Lancet Infect Dis 19:e143–e147
Tenforde MW, Gertz AM, Lawrence DS et al (2020) Mortality from HIV-associated meningitis in sub-Saharan Africa: a systematic review and meta-analysis. J Int AIDS Soc 23:e25416
PubMed PubMed Central Google Scholar
Rajasingham R, Govender NP, Jordan A et al (2022) The global burden of HIV-associated cryptococcal infection in adults in 2020: a modelling analysis. Lancet Infect Dis 22:1748–1755
PubMed PubMed Central Google Scholar
Huang Y, Jin X, Wu F et al (2023) Cryptococcal meningitis in HIV-Negative patients: A 12-Year Single-Center experience in China. J Clin Med 12(2). https://doi.org/10.3390/jcm12020515
Acharya R, Khanal K, Upadhyaya P et al (2020) Diabetes mellitus as a risk factor for cryptococcal meningitis in immunocompetent. IDCases 22:e00988
PubMed PubMed Central Google Scholar
Iyer KR, Revie NM, Fu C et al (2021) Treatment strategies for Cryptococcal infection: challenges, advances and future outlook. Nat Rev Microbiol 19:454–466
PubMed PubMed Central CAS Google Scholar
Jarvis JN, Lawrence DS, Meya DB et al (2022) Single-dose liposomal amphotericin B treatment for Cryptococcal meningitis. N Engl J Med 386:1109–1120
PubMed PubMed Central CAS Google Scholar
Proposal for revised clinical and electroencephalographic classification of epileptic seizures (1981) From the commission on classification and terminology of the international league against epilepsy. Epilepsia 22:489–501
Treiman DM (1995) Electroclinical features of status epilepticus. J Clin Neurophysiol 12:343–362
Cornejo-Venegas G, Carreras X, Salcedo AS et al (2024) Cerebrospinal fluid shunting for the management of Cryptococcal meningitis: a scoping review. Ther Adv Infect Dis 11:20499361241228666
PubMed PubMed Central Google Scholar
Izumikawa K, Kakeya H, Sakai F et al (2020) Executive summary of JSMM clinical practice guidelines for diagnosis and treatment of cryptococcosis 2019. Med Mycol J 61:61–89
Wang Y, Yang M, Xia Y et al (2021) Application and evaluation of nucleic acid sequence-based amplification, PCR and cryptococcal antigen test for diagnosis of cryptococcosis. BMC Infect Dis 21:1020
PubMed PubMed Central CAS Google Scholar
van der Horst CM, Saag MS, Cloud GA, National Institute of allergy and infectious diseases mycoses study group and AIDS clinical trials group et al (1997) Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. N Engl J Med 337:15–21
Denning DW, Armstrong RW, Lewis BH et al (1991) Elevated cerebrospinal fluid pressures in patients with Cryptococcal meningitis and acquired immunodeficiency syndrome. Am J Med 91:267–272
Fessler RD, Sobel J, Guyot L et al (1998) Management of elevated intracranial pressure in patients with Cryptococcal meningitis. J Acquir Immune Defic Syndr Hum Retrovirol 17:137–142
Liu Y, Peng X, Weng W et al (2019) Efficacy of ventriculoperitoneal shunting in patients with cryptococcal meningitis with intracranial hypertension. Int J Infect Dis 88:102–109
Liu L, Zhang R, Tang Y, Lu H (2014) The use of ventriculoperitoneal shunts for uncontrollable intracranial hypertension in patients with HIV-associated cryptococcal meningitis with or without hydrocephalus. Biosci Trends 8:327–332
Tao R, Xu L, Guo Y et al (2022) Ventriculoperitoneal shunt is associated with increased cerebrospinal fluid protein level in HIV-infected cryptococcal meningitis patients. BMC Infect Dis 22:286
PubMed PubMed Central CAS Google Scholar
Zhang C, Tan Z, Tian F (2020) Impaired consciousness and decreased glucose concentration of CSF as prognostic factors in immunocompetent patients with Cryptococcal meningitis. BMC Infect Dis 20(1):69
Comments (0)